< Back | |
12 May 2017 | |
The Exchange has sought clarification from Torrent Pharmaceuticals Ltd with respect to news article appearing on Bloombergquint on May 12, 2017 titled "Torrent Pharma Gets Four U.S. FDA Observations for Indrad Plant."<BR><BR>The reply is awaited. | |
View all announcements for TORRENT PHARMACEUTICALS LTD. | Source: BSE India |